WATCH: Trump Announces Most Favored Nation Drug Pricing Will Now Be Available Under Medicaid in All 50 States
President Trump on Friday announced in the Oval Office that all 50 states have signed on to his agreements on most-favored-nation pricing on prescription drugs under Medicaid. "This will save states billions and billions of dollars per year on drugs and allow them to invest those savings in providing better health care and higher quality service for the American people," Trump told reporters. The post WATCH: Trump Announces Most Favored Nation Drug Pricing Will Now Be Available Under Medicaid in All 50 States appeared first on The Gateway Pundit.
TL;DR
- All 50 states have signed on to most-favored-nation (MFN) drug pricing agreements under Medicaid.
- The MFN pricing aims to match the lowest prescription drug prices paid in other developed nations.
- President Trump stated this will save states billions annually and allow for investment in better healthcare.
- Taxpayers are estimated to save $64.3 billion on Medicaid costs over the next decade.
- Agreements have been secured with 26 pharmaceutical companies, with more expected to join.
- The GENEROUS Medicaid Payment Model includes rebates to ensure prices do not exceed MFN rates.
- The model covers hundreds of drugs, including those for oncology, diabetes, and asthma.
- Medicaid programs have already benefited from free prescriptions of Eliquis due to these deals.